Skip to content

A multicenter study for sample collection and verification, clinical validity and mechanism based on ADHD diagnositic software

A multicenter study for sample collection and verification, clinical validity and mechanism based on ADHD diagnositic software

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024954
Enrollment
Unknown
Registered
2019-08-04
Start date
2019-08-04
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder

Interventions

Gold Standard:DSM-5 for ADHD Diagnostic criteria
Index test:ADHD&#32
Diagnostic&#32

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) Establishment of norms: normal children and adolescents aged between 6 and 18 years; (2) Clinical control: children and adolescents aged between 6 and 18 who met the DSM-5 diagnostic criteria for attention deficit hyperactivity disorder (ADHD) and normal controls.

Exclusion criteria

Exclusion criteria: Children with known neurological disorders, severe head injury, mental retardation, other chronic diseases, long-term drug use, and primary mental disorders (such as depression, anxiety, psychosis), children in the normal control group and first-degree relatives of adolescents with ADHD.

Design outcomes

Primary

MeasureTime frame
Attention;Hyperactivity;Impulsiveness;Timeliness;Diagnostic Scale;

Secondary

MeasureTime frame
Basic demographic data Questionaire;

Countries

China

Contacts

Public ContactChen Wen-Xiong

Guangzhou Women and Children's Medical Center

gzchcwx@126.com+86 18902268798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026